tubulin inhibitors (Celgene/EntreMed)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug Nametubulin inhibitors (Celgene/EntreMed)
Drug Alias NameENMD-1420CC-5079ENMD-1916ENMD-1427
ClassificationSmall molecules
Mechanisms of ActionTubulin inhibitorsCell cycle inhibitorsApoptosis stimulants +[4] 
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCelgene Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCasi Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A